These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 38436783

  • 1. STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma.
    Zhao Z, Chu Y, Feng A, Zhang S, Wu H, Li Z, Sun M, Zhang L, Chen T, Xu M.
    Cell Oncol (Dordr); 2024 Aug; 47(4):1295-1314. PubMed ID: 38436783
    [Abstract] [Full Text] [Related]

  • 2. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X, Li Y, Wang W, Wang S, Hou J, Zhang A, Lv B, Gao C, Yan Z, Pang D, Lu K, Ahmad NH, Wang L, Zhu J, Zhang L, Zhuang T, Li X.
    Theranostics; 2020 Aug; 10(21):9443-9457. PubMed ID: 32863938
    [Abstract] [Full Text] [Related]

  • 3. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
    Wang Y, Lyu Z, Qin Y, Wang X, Sun L, Zhang Y, Gong L, Wu S, Han S, Tang Y, Jia Y, Kwong DL, Kam N, Guan XY.
    Theranostics; 2020 Aug; 10(25):11535-11548. PubMed ID: 33052231
    [Abstract] [Full Text] [Related]

  • 4. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.
    He Z, Chen J, Chen X, Wang H, Tang L, Han C.
    J Cell Physiol; 2021 Jan; 236(1):107-120. PubMed ID: 33459391
    [Abstract] [Full Text] [Related]

  • 5. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    Yang F, Sun Z, Wang D, Du T.
    BMC Cancer; 2022 Mar 22; 22(1):308. PubMed ID: 35317779
    [Abstract] [Full Text] [Related]

  • 6. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L, Zhou S, Guo E, Chen X, Yang J, Li X.
    Pflugers Arch; 2020 Aug 22; 472(8):1041-1049. PubMed ID: 32533239
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway.
    Yan S, Xu J, Liu B, Ma L, Feng H, Tan H, Fang C.
    Bioengineered; 2021 Dec 22; 12(1):682-696. PubMed ID: 33602031
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y, Yi J, Zhang K, Bai F, Feng B, Wang R, Chu X, Chen L, Song H.
    J Exp Clin Cancer Res; 2017 Nov 16; 36(1):161. PubMed ID: 29145896
    [Abstract] [Full Text] [Related]

  • 9. microRNA-155 acts as an oncogene by targeting the tumor protein 53-induced nuclear protein 1 in esophageal squamous cell carcinoma.
    Zhang J, Cheng C, Yuan X, He JT, Pan QH, Sun FY.
    Int J Clin Exp Pathol; 2014 Nov 16; 7(2):602-10. PubMed ID: 24551280
    [Abstract] [Full Text] [Related]

  • 10. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
    Hu J, Dai C, Ding Z, Pan Y, Lu L, Bao J, Zheng J.
    BMC Cancer; 2024 Jun 24; 24(1):759. PubMed ID: 38914958
    [Abstract] [Full Text] [Related]

  • 11. CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.
    Du Y, Yan D, Yuan Y, Xu J, Wang S, Yang Z, Cheng W, Tian X, Kan Q.
    Cell Cycle; 2019 Feb 24; 18(4):452-466. PubMed ID: 30722725
    [Abstract] [Full Text] [Related]

  • 12. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z, Gu S, Lu T, Wu K, Li L, Dong C, Zhou Y.
    J Exp Clin Cancer Res; 2020 Jul 29; 39(1):144. PubMed ID: 32727517
    [Abstract] [Full Text] [Related]

  • 13. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C, Zhu M, Zhu J, Lu Q, Shi B, Sun B, Chen H.
    Oncol Rep; 2021 Jan 29; 45(1):129-138. PubMed ID: 33416144
    [Abstract] [Full Text] [Related]

  • 14. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y, Zhi Y, Song H, Zong M, Yi J, Mao G, Chen L, Huang G.
    J Exp Clin Cancer Res; 2019 Aug 22; 38(1):369. PubMed ID: 31438989
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
    Wang H, Li H, Yu Y, Jiang Q, Zhang R, Sun H, Xing W, Li Y.
    Cell Cycle; 2021 Jan 22; 20(1):39-53. PubMed ID: 33345719
    [Abstract] [Full Text] [Related]

  • 16. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X, Jiang J, Zhao Y, Wang X, Zhang C, Zhuan L, Zhang D, Zheng Y.
    J Exp Clin Cancer Res; 2020 Jul 11; 39(1):133. PubMed ID: 32653032
    [Abstract] [Full Text] [Related]

  • 17. m6 A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis.
    Nagaki Y, Motoyama S, Yamaguchi T, Hoshizaki M, Sato Y, Sato T, Koizumi Y, Wakita A, Kawakita Y, Imai K, Nanjo H, Watanabe H, Imai Y, Minamiya Y, Kuba K.
    Genes Cells; 2020 Aug 11; 25(8):547-561. PubMed ID: 32449584
    [Abstract] [Full Text] [Related]

  • 18. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X, Zhu R, Luo A, Zhou H, Ding F, Yang H, Liu Z.
    J Exp Clin Cancer Res; 2020 Aug 31; 39(1):175. PubMed ID: 32867821
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
    Chen X, Wang J, Song L, Yu Y, Shi M, Jiang W, Liu X, He X.
    Thorac Cancer; 2022 Sep 31; 13(18):2592-2605. PubMed ID: 35950373
    [Abstract] [Full Text] [Related]

  • 20. FOXO1 mediates hypoxia-induced G0/G1 arrest in ovarian somatic granulosa cells by activating the TP53INP1-p53-CDKN1A pathway.
    Li C, Liu Z, Wu G, Zang Z, Zhang JQ, Li X, Tao J, Shen M, Liu H.
    Development; 2021 Jul 15; 148(14):. PubMed ID: 34152408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.